SCHEMBL23937925

SCHEMBL23937925

CNC(=O)c1nn(O)c2c1CSCC2

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HDAC10 Q969S8 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20674457 0.85 GRM5 (0.38) HDAC10HDAC6
SCHEMBL20673856 0.80 CCNA2 (0.31)
SCHEMBL23937913 0.78 GRM5 (0.41)
SCHEMBL21958655 0.77 GRM5 (0.40)
SCHEMBL23937897 0.73 PARP1 (0.33)
SCHEMBL23937921 0.66
SCHEMBL21959600 0.66 LMNA (0.34)
SCHEMBL23937898 0.66
SCHEMBL20674215 0.62 GRM5 (0.55)
SCHEMBL23937909 0.59 PARP1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed